Study Stopped
different protocol started, new registration
Cervical Pessary in Women With Arrested Preterm Labor and Short Cervix
PWK
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Preterm birth (PTB), defined as birth between 20 and 36 6/7 weeks, is responsible for the majority of the neonatal morbidity and mortality in the United States, and 35% of all U.S. healthcare spending on infants. Globally, about 28% of the 4 million annual neonatal deaths are directly attributable to PTB. Preterm labor (PTL) is the final pathway for about 50% of all PTB. Tocolytic agents are drugs that can slow or stop labor contractions in the attempt to delay births preceded by PTL. Primary tocolysis is defined as tocolysis given on initial presentation of women with PTL. In most of these women, PTL stops, but as their risk of PTB remains high, some have advocated use of maintenance tocolysis, i.e. tocolysis after arrested PTL. So far, no maintenance tocolytic agent has been shown to be beneficial in preventing PTB. The aim of this study is to evaluate the efficacy of maintenance tocolysis with Arabin pessary compared to standard care in singleton gestations with arrested PTL and with short transvaginal ultrasound (TVU) cervical length (CL) \<25mm
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 27, 2016
CompletedFirst Posted
Study publicly available on registry
July 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedNovember 19, 2018
November 1, 2018
1.4 years
July 27, 2016
November 15, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Spontaneous preterm birth (SPTB)
Less than 34 weeks gestation
Secondary Outcomes (9)
Spontaneous preterm birth (SPTB)
Less than 37,35,32,28 and 24 weeks gestation
Gestational age at delivery
Delivery (at birth)
Latency
Delivery (at birth)
Birth weight
Delivery (at birth)
Admission to neonatal intensive care unit
Delivery (at birth)
- +4 more secondary outcomes
Study Arms (2)
Cervical pessary
EXPERIMENTALArabin cervical pessary
Standard care
NO INTERVENTIONNo treatment
Interventions
Eligibility Criteria
You may qualify if:
- ages
- Singleton pregnancy
- (0) - 34(6) weeks of gestation
- Arrested preterm labor after primary tocolysis
- Transvaginal ultrasound cervical length less than 25mm at admission
- Agreement to regular follow-up and provision of written informed consent
You may not qualify if:
- pessary and no cerclage in situ
- vaginal bleeding
- placeta previa/accreta
- multiple gestations
- \<24(0) or \>24(6) weeks of gestation
- Cervical dilatation greater than 3 cm
- Chorioamnionitis
- Major fetal abnormalities
- Abruptio placentae
- PPROM
- Polyhydramnios or oligohydramnios
- IUGR/FGR with or without Doppler abnormalities
- Preeclampsia or pregnancy-related hypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Naples Federico II
Naples, 80100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
July 27, 2016
First Posted
July 29, 2016
Study Start
July 1, 2016
Primary Completion
December 1, 2017
Study Completion
March 1, 2018
Last Updated
November 19, 2018
Record last verified: 2018-11